Autologous Human Schwann Cells in Peripheral Nerve Repair

Summary

The purpose of this study is to assess the safety of autologous human Schwann cell (ahSC) augmentation of nerve autograft repair in participants with severe peripheral nerve injury (PNI). For humans with acute severe PNI, the hypothesis is that augmentation of nerve autograft repair with ahSCs can potentially enhance axonal regeneration and myelin repair and thus improve functional recovery.

Timeline

Start

2019-09-24

Primary completion

2025-12-04

Completion

2025-12-04

Drugs

Indications